Creator: Troester, Melissa A, Herschkowitz, Jason I, Oh, Daniel S, He, Xiaping, Hoadley, Katherine A, Barbier, Claire S, Perou, Charles M
Abstract Background Breast cancer subtypes identified in genomic studies have different underlying genetic defects. Mutations in the tumor suppressor p53 occur more frequently in estrogen receptor (ER) negative, basal-like and HER2-amplified tumors (more)
pdf (1 MB)
Additional file 1 Microsoft Excel spreadsheet (196 kB) containing lists of genes for which expression levels were significantly associated with p53 loss (in 2-class SAM analyses).
Collection: BioMed Central
Date Deposited: 2016-07-08
Date Created: 2016-07-08
xls (196 KB)